{"nct_id":"NCT02812875","title":"A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2016-05","start_date_type":null,"primary_completion_date":"2020-05-07","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRIS"]}